I remember back at the beginning of the pandemic when we were seeing lots of patients arriving in the ED in extremis. The now familiar picture of the deeply hypoxic […]
JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial. St Emlyn’s Read More
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s Read More
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. This week the
JC: Aspirin is not effective for hospitalised COVID19 patients. St Emlyn’s Read More
Although this post is mainly about the new Anaphylaxis Guidelines published recently, please bear with me while we get a little nerdy with some physiology first… For anyone starting out
Anaphylaxis – A Guideline Update Read More
The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for
JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s Read More
Our regular podcast round up from February 2021. Iain and Simon highlight the key learning points from this month on the St Emlyn’s blog and podcast. Please remember to subscribe
Podcast – February 2021 Monthly Round Up Read More
The latest results on the use of convalescent plasma in Covid-19 are now out from the RECOVERY trial as a pre-print. As you know we have already covered the trial
JC: Convalescent plasma (still) does not work in COVID-19. St Emlyn’s Read More
This week the RECOVERY trial has released the first results from the Colchicine arm of the trial. We await the pre-print and the peer reviewed paper, but we are already
Colchicine does not improve mortality in COVID19. St Emlyn’s Read More
